Andrew Winokur, PhD, MD | Psychiatrist.com

Esketamine Nasal Spray and Adverse Events Over Time

Original Research

Esketamine Nasal Spray and Adverse Events Over Time

September 19, 2022

This study looked at the occurrence and severity of adverse events over time with esketamine nasal spray in MDD patients also receiving an oral antidepressant.

David J. Williamson, Jagadish P. Gogate, Jennifer K. Kern Sliwa, et al

Original Research

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

December 15, 2012

George I. Papakostas, Ottavio V. Vitolo, Waguih W. IsHak, et al

Original Research

Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia

October 15, 2003

Andrew Winokur, Nicholas A. DeMartinis III, Daniel P. McNally, et al

Academic Highlights

The Pharmacologic Rationale for the Clinical Use of Antidepressants

November 15, 1997

Trond Aarre, Otto Benkert, Jonathan R. T. Davidson, et al

Original Research

A Comparison of Nefazodone and Fluoxetine on Mood and on Objective, Subjective, and Clinician-Rated Measures of Sleep in Depressed Patients: A Double-Blind, 8-Week Clinical Trial

May 15, 1997

J. Christian Gillin, Mark Rapaport, Milton K. Erman, et al